These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29308018)

  • 1. Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment.
    Lindgren HI; Pärsson H; Gottsäter A; Bergman S
    Clin Med Insights Cardiol; 2017; 11():1179546817747528. PubMed ID: 29308018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All Cause Chronic Widespread Pain is Common in Patients with Symptomatic Peripheral Arterial Disease and is Associated with Reduced Health Related Quality of Life.
    Lindgren H; Gottsäter A; Qvarfordt P; Bergman S
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):205-10. PubMed ID: 27344484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial.
    Nordanstig J; Taft C; Hensäter M; Perlander A; Osterberg K; Jivegård L
    Circulation; 2014 Sep; 130(12):939-47. PubMed ID: 25095886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain - results from the EPIFUND study.
    Nicholl BI; Macfarlane GJ; Davies KA; Morriss R; Dickens C; McBeth J
    Pain; 2009 Jan; 141(1-2):119-26. PubMed ID: 19059720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication.
    Nordanstig J; Taft C; Hensäter M; Perlander A; Österberg K; Jivegård L
    Br J Surg; 2016 Sep; 103(10):1290-9. PubMed ID: 27220310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial.
    Nordanstig J; Gelin J; Hensäter M; Taft C; Österberg K; Jivegård L
    Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):220-7. PubMed ID: 21397530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Choice - Cost Effectiveness of Primary Stenting in the Superficial Femoral Artery for Intermittent Claudication: Two Year Results of a Randomised Multicentre Trial.
    Djerf H; Svensson M; Nordanstig J; Gottsäter A; Falkenberg M; Lindgren H
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):576-582. PubMed ID: 34454817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise for intermittent claudication.
    Lane R; Ellis B; Watson L; Leng GC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD000990. PubMed ID: 25037027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
    Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.
    Bosch JL; Hunink MG
    Qual Life Res; 2000; 9(6):591-601. PubMed ID: 11236850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of revascularization in patients with intermittent claudication.
    Djerf H; Falkenberg M; Jivegård L; Lindgren H; Svensson M; Nordanstig J
    Br J Surg; 2018 Dec; 105(13):1742-1748. PubMed ID: 30357819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported health status and disease-specific quality of life one year after treatment for peripheral arterial disease in clinical practice.
    Larsen ASF; Reiersen AT; Nådland IH; Wesche J
    Health Qual Life Outcomes; 2020 Jul; 18(1):235. PubMed ID: 32680523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P; Migliacci R; Di Sante G; Nenci GG;
    Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's experiences of the journey to chronic widespread pain: a qualitative study.
    Svensson M; Larsson I; Aili K
    BMC Musculoskelet Disord; 2020 Jun; 21(1):417. PubMed ID: 32605553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study.
    Farkas K; Kolossváry E; Járai Z
    Vasa; 2020 Apr; 49(3):235-242. PubMed ID: 31983287
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of a Medical vs Revascularization Intervention for Intermittent Leg Claudication Based on Patient-Reported Outcomes.
    Devine EB; Alfonso-Cristancho R; Yanez ND; Edwards TC; Patrick DL; Armstrong CA; Devlin A; Symons RG; Meissner MH; Derrick EL; Lavallee DC; Kessler LG; Flum DR;
    JAMA Surg; 2016 Oct; 151(10):e162024. PubMed ID: 27760274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional electrical stimulation improves quality of life by reducing intermittent claudication.
    Embrey DG; Alon G; Brandsma BA; Vladimir F; Silva A; Pflugeisen BM; Amoroso PJ
    Int J Cardiol; 2017 Sep; 243():454-459. PubMed ID: 28595744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Feasibility of Pain management and Patient Education for Physical Activity in Intermittent claudication (PrEPAID): protocol for a randomised controlled trial.
    Abaraogu UO; Dall PM; Brittenden J; Stuart W; Tew GA; Godwin J; Seenan CA
    Trials; 2019 Apr; 20(1):222. PubMed ID: 30992033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.